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Abstract
Background:  Skin  tumours  that  originate  in  the  external  ear  are  common  in  individuals  with
type 1  skin  and  phenotype  1  and  2.  The  skin  cancer  is  associated  with  chronic  or  intermittent,
but intense  sunlight.  The  most  common  malignant  tumour  is  basal  cell  carcinoma,  followed  by
squamous cell  carcinoma  and  melanoma.  The  diagnosis  of  squamous  cell  skin  cancer  in  head
and neck  area  is  usually  made  in  the  advanced  stages  and  has  a  poor  prognosis.
Material  and  methods:  A  cross-sectional,  retrospective  analysis  was  performed  on  the  database
of patients  with  skin  cancer  of  the  external  ear  treated  between  2011  and  2014.  Histology
type, stage,  rate  of  clinical  and  occult  metastases,  and  rate  of  loco-regional  recurrence  were
evaluated.
Results: Of  the  42  patients  included  there  were,  25  squamous  cell  carcinomas,  11  basal  cell
carcinomas,  and  6  invasive  melanomas.  The  rate  of  lymph  node  metastases  in  patients  with
squamous cell  carcinoma  was  32%,  mostly  in  the  parotid  and  peri-parotid  region,  7%  of  them
with capsular  rupture,  2/17  were  staged  as  cN0,  and  11.7%  had  occult  metastases.  All  patients
with nodal  metastasis  were  classiﬁed  as  T2  with  ulceration.
None  of  the  patients  with  basal  cell  carcinoma  had  lymph  node  metastases.
All melanomas  were  superﬁcial  extension  type  with  mean  level  of  Breslow  of  3  mm.  All  under-
went lymphatic  mapping  and  sentinel  node  biopsy,  with  only  one  having  metastases  in  the
sentinel node.
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Conclusion:  The  most  frequent  tumour  in  the  external  ear  in  this  series  was  squamous  cell
carcinoma. The  possibility  of  lymph  node  metastases  is  associated  with  tumour  size  (T).  Node
dissection  should  be  systematic  in  patients  with  T2  or  greater.
© 2015  Academia  Mexicana  de  Cirugía  A.C.  Published  by  Masson  Doyma  México  S.A.  This  is
an open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/
by-nc-nd/4.0/).
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Características  clínicas  de  los  tumores  malignos  originados  en  el  pabellón  auricular
Resumen
Antecedentes:  Los  tumores  cutáneos  que  se  originan  en  el  pabellón  auricular  son  frecuentes
en individuos  con  piel  tipo  1  y  fenotipos  1  y  2;  estos  están  asociados  a  la  insolación  crónica
o intermitente,  pero  intensa.  El  tumor  maligno  más  frecuente  es  el  carcinoma  basocelular,
seguido  del  epidermoide  y  del  melanoma.  Suelen  diagnosticarse  en  etapas  tardías  y  tener  mal
pronóstico.
Material y  métodos:  Estudio  transversal,  con  análisis  retrospectivo  de  la  base  de  datos  de
pacientes con  cáncer  de  piel,  que  fueron  tratados  entre  2011  y  2014.  Se  incluyen  los  pacientes
con tumor  en  el  pabellón  auricular.  Se  evaluó:  tipo  histológico,  etapa,  tasa  de  metástasis  clínicas
y ocultas,  y  tasa  de  recurrencia  locorregional.
Resultados:  Incluimos  42  pacientes  con  25  carcinomas  epidermoides,  11  basocelulares  y  6
melanomas  invasores.  La  tasa  de  metástasis  ganglionares  en  pacientes  con  carcinoma  epider-
moide fue  32%,  la  mayoría  en  la  parótida  y  la  región  periparotídea;  7%  con  rotura  capsular,  2/17
se etapiﬁcaron  como  cN0,  tuvieron  metástasis  ocultas  (11.7%).  Todos  los  pacientes  cN+  fueron
clasiﬁcados  como  T2,  con  ulceración.  Ninguno  de  los  pacientes  con  carcinoma  basocelular  tuvo
metástasis  ganglionares.
Todos  los  melanomas  fueron  de  tipo  de  extensión  superﬁcial,  con  media  de  Breslow  de  3  mm,  y
a todos  se  les  realizó  mapeo  linfático  y  biopsia  del  ganglio  centinela;  solo  uno  tuvo  metástasis
en el  ganglio  centinela.
Conclusión:  El  tumor  más  frecuente  en  el  pabellón  auricular  en  la  presente  serie  es  el  carcinoma
epidermoide;  la  posibilidad  de  metástasis  ganglionares  se  asocia  al  taman˜o  del  tumor  (T),  la
disección ganglionar  debe  de  ser  sistemática  en  pacientes  con  T2  o  mayores.
© 2015  Academia  Mexicana  de  Cirugía  A.C.  Publicado  por  Masson  Doyma  México  S.A.  Este  es
un artículo  Open  Access  bajo  la  licencia  CC  BY-NC-ND  (http://creativecommons.org/licenses/
by-nc-nd/4.0/).
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kin  cancer  is  the  most  common  tumour  in  the  economy,1
lthough  its  prevalence  is  often  under-recorded.  This  is
ecause  many  cases  are  resolved  as  outpatients  and  are  not
eported,  and  because  many  of  these  tumours,  since  they
re  not  a  cause  of  mortality  are  not  duly  registered.  Fur-
hermore,  most  epidemiological  studies  when  referring  to
kin  cancer  only  include  skin  melanomas,  and  not  basal  cell
arcinomas,  squamous  cell  carcinomas  or  carcinomas  of  skin
nnexes.2
WHO  reports  that  basal  cell  cancer  is  the  most  common  of
he  skin  cancers,  followed  by  squamous  cell  carcinoma,  and
elanoma.  Carcinomas  of  skin  annexes  are  less  common.
In  Mexico,2,3 16,000  new  cases  of  skin  cancer  are  recorded
very  year,  with  an  estimated  prevalence  of  13.6%,  and  it
anks  ﬁfth  amongst  all  body  tumours.
Seventy  percent  of  skin  cancers  are  located  in  the  head
nd  neck  area,  80%  of  these  are  basal  cell  carcinomas.  The
ost  common  site  is  the  facial  region;  there  is  a  speciﬁc
rea  known  as  the  ‘‘mask  area’’,  which  comprises  the  peri-
rbital,  peribuccal,  nasal,  perinasal  and  auricular  regions.
w
t
Iumours  arising  in  this  area  are  considered  high  risk,  since
hey  have  a  poor  prognosis  compared  with  tumours  which
riginate  in  other  areas  of  the  face,  the  scalp  and  outside
he  head  and  neck.  Tumours  originating  in  the  mask  area
resent  greater  rates  of  local  recurrence,  probably  because
he  excision  margins  are  difﬁcult,  as  they  are  in  areas  where
rgans  important  for  function  hinder  their  removal.  Further-
ore,  squamous  cell  carcinomas  arising  in  these  sites  are
sually  accompanied  by  a  large  percentage  of  lymph  node
etastases  which  are  palpable  or  occult  at  the  time  of  diag-
osis,  and  which  have  a  negative  impact  on  the  prognosis  for
hese  patients.  The  incidence  of  lymph  node  metastases  is
reater  in  patients  with  squamous  cell  carcinomas  arising  in
he  mask  area,  compared  with  other  sites,  both  inside  and
utside  the  cervico-facial  area.4,5
The  external  ear  is  included  in  the  mask  area,  and  there-
ore  neoplasias  arising  from  the  external  ear  have  been
eported  as  having  a  poor  prognosis,  with  high  temporal  inﬁl-
ration  of  the  tumour  or  inﬁltration  of  the  auditory  canal,
ith  lymph  node  metastases  principally  in  the  parotid  gland,
he  periparotid  region,  and  the  high  levels  of  the  neck  (IIA,
IB  and  VA).1
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dClinical  characteristics  of  malignant  tumours  originating  in  t
The  major  cause  of  skin  cancer  is  immoderate  exposure
to  the  sun,  and  is  more  common  in  individuals  with  pale  skin,
eyes  and  hair  (phenotype  1).6
Other  risk  factors  have  been  identiﬁed  such  as:
immunosuppression7 (patients  with  chronic  kidney  failure  or
under  treatment  with  immunosuppressants),  human  papil-
loma  virus,  oncogenetic  alterations  (PTCH1  mutation  in
basal  cell  carcinoma,  and  mutations  in  the  p53  tumour  sup-
pressor  gene  in  squamous  cell  carcinoma)  and  chronically
inﬂamed  or  irritated  skin  areas.8--10 However,  the  sun  is  the
most  signiﬁcant  risk  factor;  intense  and  acute  exposure  is
associated  with  basal  cell  carcinoma,  and  intermittent  but
chronic  exposure  is  associated  with  squamous  cell  carci-
noma,  and  cutaneous  melanoma.
The  most  signiﬁcant  prognostic  factors  in  skin  cancer  are:
histological  type,  tumour  size,  stage  of  the  disease,  location
(prognosis  is  poorer  in  the  mask  area),  histological  grade  and
neuroinvasion.11,12
Carcinomas  arising  in  the  ear  area,  due  to  their  loca-
tion,  are  considered  to  be  more  aggressive  and  to  have
a  poorer  prognosis  when  compared  to  those  located  on
the  extremities  or  the  trunk.1 They  are  also  associated
with  a  greater  frequency  of  lymph  node  metastases,  both
occult  and  clinical,  when  they  are  diagnosed,  and  these
can  be  parotid  or  periparotid,  and  can  spread  locally  to  the
ear  canal  and  the  mastoid  region.13--15 Lymph  node  metas-
tases  predominate  in  patients  with  bulky  tumours  (T2  and
T3)  when  they  ulcerate,  when  the  Breslow’s  thickness  is
greater  than  4  mm,  and  when  there  is  ear  cartilage  inﬁltra-
tion.  A  tumour  with  these  features  can  present  lymph  node
metastases,  although  these  are  not  evident  at  the  time  of
diagnosis,  and  therefore  it  is  considered  that  they  are  all
an  indication  for  lymph  node  dissection  of  the  risk  area,
even  if  the  patient  does  not  have  palpable  lymph  nodes
(cNO).15,16
The  objective  of  this  study  was  to  discover  the  clini-
cal  features  of  patients  with  skin  cancer  arising  in  the  ear,
the  rate  of  lymph  node  metastases,  and  locoregional  recur-
rence.
Material and methods
This  was  a  cross-sectional,  retrospective  study  of  our  depart-
ment’s  database  of  patients  with  skin  cancer  located  in  the
ear,  and  who  were  treated  over  3  years,  between  1  January
2011  and  1  January  2013.
All  patients  with  skin  cancer  arising  in  the  external
ear  were  included.  Patients  with  preneoplastic  lesions,  and
lentigo  maligna  melanoma  were  excluded  from  the  study.
All  the  patients  underwent  diagnostic  and  staging  biopsy
at  the  time  of  consultation,  and  were  evaluated  with  high-
resolution  ultrasound  of  the  neck,  and  the  parotid  and
periparotid  region  on  the  same  side  as  the  lesion,  if  lymph
node  metastases  had  not  been  palpated  at  the  time  of  eval-
uation.
Before  the  procedure,  all  the  patients  underwent  a
cardiovascular  assessment  in  order  to  rule  out  underlying
disease,  which  would  increase  the  therapeutic  risk.
We  assessed  the  histology,  stage,  and  presence  of  lymph
node  metastasis  at  the  time  of  diagnosis,  the  incidence  of
occult  metastasis  in  patients  with  no  metastasis  found  on
d
p
bxternal  ear  475
alpation  or  on  ultrasound  imaging,  in  patients  undergoing
ymph  node  dissection,  and  the  treatment  given.
esults
orty-two  patients  were  identiﬁed  with  tumours  arising  in
he  external  ear,  14  women  and  28  men  with  a  mean  age  of
0,  and  with  a range  of  29--94  years  of  age.
Thirty-two  patients  had  received  no  treatment  whatso-
ver,  and  10  had  recurrent  tumours  after  previous  treatment
hich  they  had  received  outside  our  hospital.
istology
wenty-ﬁve  were  diagnosed  as  invasive  squamous  cell  carci-
omas,  11  basal  cell  carcinomas,  and  6  melanomas.
At  the  time  of  diagnosis,  32%  (8  patients)  of  the  25
atients  with  squamous  cell  carcinoma  had  lymph  node
etastasis,  all  located  in  the  periparotid  region  (buccinator
nd  masticator  lymph  nodes),  the  parotid  region  and  levels
IA  and  IIB;  in  17  patients  no  lymph  node  metastases  were
ound  on  palpation  or  ultrasound  imaging,  at  the  time  of
iagnosis  (cN0),  all  underwent  lymph  node  dissection  and  2
ere  classiﬁed  as  pN+  (11.7%),  both  patients  had  pT2  stage
umours,  which  were  ulcerated,  inﬁltrating  the  ear  carti-
age;  the  metastases  in  both  were  located  in  the  periparotid
ymph  nodes.
The  incidence  of  lymph  node  metastasis  in  patients  with
quamous  cell  carcinoma,  both  clinical  and  occult,  was  43%,
nd  lymph  node  capsule  rupture  was  found  in  7%.
Of  the  11  patients  with  basal  cell  carcinoma,  7 were  solid
nd  4  morphea  in  type;  none  of  them  had  palpable  lymph
ode  metastasis  in  the  parotid  or  cervical  region,  and  they
nderwent  wide  resection  of  the  lesion  only.
One  of  these  female  patients  had  a history  of  recurrence
fter  radiotherapy  and  required  wide  en  bloc  resection  with
he  mastoid  apophysis.  This  patient  presented  a  second  mas-
ive  local  recurrence  in  the  temporal  region  8 months  after
escue  surgery,  and  was  a  candidate  for  palliative  treatment
nly.
In  the  6  patients  with  cutaneous  melanoma,  the  mean
reslow’s  thickness  was  3  mm.  They  all  had  superﬁcial
preading  melanoma,  the  6  presented  ulceration  and  mitotic
ndex  more  than  one  mitotis  per  mm2,  2  were  classiﬁed  as
T2B,  and  4  as  pT3B.
reatment
quamous  cell  carcinoma
ll  the  patients  underwent  full  resection  of  the  lesion,
nd  lymph  node  dissection  of  the  risk  area.  If  there  were
ymph  node  metastases  which  were  palpable  or  detected  on
ltrasound  imaging,  a  parotidectomy,  dissection  of  the  buc-
inator  and  masticatory  glands,  and  modiﬁed  radical  neck
issection  type  3,  including  levels  I--V,  were  performed.In  patients  with  no  clinical  metastases,  or  metastases
etected  by  imaging,  the  lymph  nodes  were  staged  by  lym-
hatic  mapping  with  sentinel  node  biopsy  in  7  patients,  and
y  elective  parotid  and  cervical  dissection  in  10.
4h
p
t
n
(
l
c
m
o
B
A
p
t
u
m
t
m
C
A
(
w
n
p
t
i
m
l
p
a
L
O
a
w
l
p
t
w
t
r
n
D
T
c
m
a
t
t
n
u
t
i
t
c
o
w
i
t
t
n
ﬁ
s
f
m
i
b
i
e
b
a
p
o
n
t
d
d
c
A
m
c
r
n
t
m
r
q
w
f
a
l
i
p
t
r
i
s
p76  
Of  the  7  patients  who  underwent  mapping,  only  one  (14%)
ad  metastasis  in  the  sentinel  node  located  in  the  peri-
arotid  region,  and  surgery  was  completed  with  parotidec-
omy  and  lymph  node  dissection.  No  further  metastatic
odes  were  found  in  the  specimen  from  this  patient.
Of  the  10  cN0  patients  who  underwent  elective  dissection
parotidectomy  and  neck  dissection),  only  one  (10%)  had  a
ymph  node  metastasis  in  the  intraparotid  region.
None  of  the  patients  were  given  combined  adjuvant
hemoradiotherapy,  but  the  patients  with  more  than  3
etastatic  lymph  nodes  received  radiotherapy  on  the  site
f  the  primary  in  the  neck.
asal  cell  carcinoma
ll  the  patients  underwent  wide  resection  of  the  ear,  with
ostoperative  evaluation  of  the  section  margins  to  ensure
hat  there  was  no  tumour  inﬁltration.  None  of  the  patients
nderwent  lymph  node  dissection;  one  of  them  underwent
astoid  resection  with  preservation  of  the  facial  nerve  due
o  inﬁltration  into  the  temporal  petrous  bone.  The  section
argins  were  negative  in  all  of  the  patients.
utaneous  melanoma
ll  the  patients  were  staged  as  cN0  at  the  time  of  diagnosis
with  no  palpable  lymph  nodes),  and  all  of  them  under-
ent  wide  resection  and  lymphatic  mapping  with  sentinel
ode  biopsy  using  the  combined  technique  (radio-colloid  and
atent  blue  V  dye).  Only  one  patient  (16%)  presented  metas-
asis  in  the  sentinel  node,  no  metastases  were  detected
n  the  sentinel  node  in  5  patients.  The  patient  with  the
etastatic  sentinel  node  underwent  parotidectomy  and
ymph  node  dissection,  the  dissected  lymph  nodes  in  this
rocedure  had  no  metastases.  None  of  the  patients  received
djuvant  therapy.
ocal  control
nly  one  patient  out  of  11  (9%)  presented  local  recurrence
fter  resection.  This  patient  had  a  morphea  carcinoma,
ith  mastoid  inﬁltration,  and  had  previously  undergone
ocal  radiotherapy.  The  neoplasm  was  progressive,  and  this
atient  was  a  candidate  for  palliative  treatment  only.
For  the  patients  with  squamous  cell  carcinoma  the  con-
rol  rate  was  68%,  the  locoregional  tumour  recurrence  rate
as  32%.  Only  one  patient  of  the  8  with  recurrence  was  able
o  undergo  rescue  surgery.  The  carcinoma  progressed  in  the
est,  and  they  died  from  the  disease  during  follow-up.
The  6  patients  with  cutaneous  melanoma  have  presented
o  recurrence  in  a  mean  follow-up  of  2  years.
iscussion
he  most  frequent  tumour  in  this  series  is  squamous
ell  carcinoma,  followed  by  basal  cell  carcinoma,  and
elanoma.  The  majority  of  these  patients  presented  in
dvanced  locoregional  stages  or  with  adverse  prognostic  fac-
ors  (ulceration  and  cartilage  inﬁltration),  which  explains
heir  outcomes.
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Squamous  cell  carcinoma  arising  in  the  skin  of  the  exter-
al  ear  has  a poor  prognosis  due  to  the  stage  at  which  it  is
sually  diagnosed,  and  the  presence  of  lymph  node  metas-
ases  which  are  both  clinically  evident  and  occult.15
The  tumour  size  and  the  lymph  node  status  are  the  most
mportant  prognostic  factors,  and  have  a  directly  propor-
ional  relationship  with  local  recurrence  and  survival.
In  this  series,  32%  of  patients  with  squamous  cell  car-
inoma  had  palpable  lymph  node  metastasis  at  the  time
f  diagnosis,  7%  of  them  had  lymph  node  capsule  rupture,
hich  is  an  adverse  prognostic  factor  that  is  likely  to  result
n  locoregional  recurrence.
The  patients  presenting  no  evidence  of  palpable  metas-
asis  (11%)  had  occult  metastasis  which  became  evident  at
he  time  of  surgical  lymph  node  staging,  either  by  sentinel
ode  biopsy  or  elective  dissection.  This  percentage  justi-
es  undertaking  surgical  staging  in  patients  with  advanced
tages  (T2  or  greater)  or  who  have  adverse  prognostic
actors.17
Level  IIB  was  inﬁltrated  in  the  8  patients  with  lymph  node
etastases  (32%)  in  this  series,  therefore  this  level  should  be
ncluded  in  therapeutic  neck  dissection,  although  the  mor-
idity  risk  associated  with  dysfunction  of  cranial  nerve  XI
s  greater.  However,  the  possibility  of  surgical  rescue  in  the
vent  of  recurrence  in  this  site  is  unlikely  due  to  the  possi-
ility  of  inﬁltration  into  the  deep  musculature  of  the  neck
nd  the  prevertebral  fascia.
Lymphadenectomy  should  include  the  parotid  region,  the
eriparotid  lymph  nodes,  and  levels  I  to  V  of  the  neck  with-
ut  resection  of  the  lymph  node  structures.1
Lymphatic  mapping  with  sentinel  node  biopsy  is  a  lymph
ode  staging  alternative  to  neck  dissection  and  parotidec-
omy.  It  enables  patients  with  occult  metastases  to  be
etected  with  the  same  degree  of  certainty  as  lymph  node
issection,  but  without  the  risk  that  this  implies,  espe-
ially  in  terms  of  the  surgical  morbidity  of  cranial  nerve  VII.
lthough  it  cannot  yet  be  considered  the  standard  treat-
ent,  it  might  be  useful  in  patients  who  have  been  staged  as
N0  clinically,  and  by  imaging,  and  those  who  have  adverse
isk  factors.17,18
In  basal  cell  carcinoma  there  is  no  indication  for  lymph
ode  resection  due  to  the  low  incidence  of  regional  metas-
ases.  However,  it  is  important  to  obtain  negative  section
argins,  since  this  is  the  most  signiﬁcant  risk  factor  for  local
ecurrence.  Controlling  these  lesions  with  radiotherapy  is
uestionable  when  the  tumour  is  bulky;  therefore  treatment
ith  surgery  is  advocated  initially.
In  cutaneous  melanoma,  the  most  signiﬁcant  prognostic
actors  are  the  mitotic  index,  the  presence  of  ulceration,
nd,  above  all,  Breslow’s  thickness.  In  patients  with  a  Bres-
ow’s  thickness  of  1  mm  or  greater,  lymph  node  staging  is
ndicated,  and  the  best  method  for  this  is  lymphatic  map-
ing  with  sentinel  node  biopsy  using  the  technique  that  gives
he  fewest  false  negatives,  and  the  highest  identiﬁcation
ate,  which  is  the  combined  technique.  This  involves  the
njection  of  dye  the  night  before  surgery,  and  10  min  before
urgery,  and  requires  lymphogammagraphy  to  identify  the
recise  site  of  lymphatic  drainage,  and  to  locate  the  ﬁrst
ode  relay  (sentinel  node).
Lymphatic  mapping  is  considered  the  standard  proce-
ure  for  the  staging  and  treatment  of  cutaneous  melanoma,
nd  although  there  is  still  debate  as  to  the  how  to  behave
he  e
1
1
1
1
1
1
1
1
1Clinical  characteristics  of  malignant  tumours  originating  in  t
if  metastases  are  found,  the  current  recommendation  is
to  complete  the  lymph  node  dissection.  With  the  neo-
plasm  which  concerns  us  here,  this  involves  performing
a  parotidectomy,  and  neck  dissection.  This  series  showed
a  rate  of  metastasis  in  the  sentinel  node  similar  to  that
reported  by  other  authors  (10--20%),  and  this  fully  justiﬁes
undertaking  the  procedure.19
Conclusion
The  2  most  common  neoplasms  which  arise  in  the  skin  of  the
ear  are  basal  cell  carcinoma  and  squamous  cell  carcinoma.
The  site  in  itself  indicates  a  poor  prognosis,  and  therefore
a  ﬁrm  diagnosis  and  early  treatment  are  necessary.  Lymph
node  staging  in  patients  with  no  palpable  regional  metas-
tases  but  with  adverse  factors,  in  the  case  of  squamous
cell  carcinoma,  should  be  routine,  and  modiﬁed  radical  neck
dissection  should  include  the  5  lymph  node  levels,  and  the
parotid  region,  if  there  are  palpable  metastases  at  the  time
of  diagnosis.
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